Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 301

1.

Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group.

Arvold ND, Armstrong TS, Warren KE, Chang SM, DeAngelis LM, Blakeley J, Chamberlain MC, Dunbar E, Loong HH, Macdonald DR, Reardon DA, Vogelbaum MA, Yuan Y, Weller M, van den Bent M, Wen PY.

Neuro Oncol. 2018 May 18. doi: 10.1093/neuonc/noy056. [Epub ahead of print]

PMID:
29788429
2.

Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients.

Miloushev VZ, Granlund KL, Boltyanskiy R, Lyashchenko SK, DeAngelis LM, Mellinghoff IK, Brennan CW, Tabar V, Yang TJ, Holodny AI, Sosa RE, Guo YW, Chen AP, Tropp J, Robb F, Keshari KR.

Cancer Res. 2018 May 16. pii: canres.0221.2018. doi: 10.1158/0008-5472.CAN-18-0221. [Epub ahead of print]

PMID:
29769199
3.

New diagnosis of cancer and the risk of subsequent cerebrovascular events.

Navi BB, Howard G, Howard VJ, Zhao H, Judd SE, Elkind MSV, Iadecola C, DeAngelis LM, Kamel H, Okin PM, Gilchrist S, Soliman EZ, Cushman M, Muntner P.

Neurology. 2018 May 4. pii: 10.1212/WNL.0000000000005636. doi: 10.1212/WNL.0000000000005636. [Epub ahead of print]

PMID:
29728524
4.

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas.

Omuro A, Beal K, McNeill K, Young RJ, Thomas A, Lin X, Terziev R, Kaley TJ, DeAngelis LM, Daras M, Gavrilovic IT, Mellinghoff I, Diamond EL, McKeown A, Manne M, Caterfino A, Patel K, Bavisotto L, Gorman G, Lamson M, Gutin P, Tabar V, Chakravarty D, Chan TA, Brennan CW, Garrett-Mayer E, Karmali RA, Pentsova E.

J Clin Oncol. 2018 Apr 23:JCO2017769992. doi: 10.1200/JCO.2017.76.9992. [Epub ahead of print]

PMID:
29683790
5.

Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-Conditioned Autologous Stem Cell Transplantation.

Scordo M, Morjaria SM, Littmann ER, Bhatia A, Chung HH, Maloy M, DeAngelis LM, Giralt SA, Taur Y, Sauter CS.

Biol Blood Marrow Transplant. 2018 Apr 18. pii: S1083-8791(18)30194-0. doi: 10.1016/j.bbmt.2018.04.013. [Epub ahead of print]

PMID:
29679773
6.

Fertility preservation in primary brain tumor patients.

Stone JB, Kelvin JF, DeAngelis LM.

Neurooncol Pract. 2017 Mar;4(1):40-45. doi: 10.1093/nop/npw005. Epub 2016 Dec 9.

7.

Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab.

Thomas A, Rosenblum M, Karimi S, DeAngelis LM, Omuro A, Kaley TJ.

CNS Oncol. 2018 Jan;7(1):7-13. doi: 10.2217/cns-2017-0025. Epub 2018 Feb 1.

8.

Reply: Arterial Thromboembolism in Non-Hodgkin Lymphoma, as the Presentation of Occult Cancer, and With Cancer Therapies.

Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM.

J Am Coll Cardiol. 2018 Jan 16;71(2):260-262. doi: 10.1016/j.jacc.2017.10.088. No abstract available.

PMID:
29325653
9.

Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial.

Navi BB, Marshall RS, Bobrow D, Singer S, Stone JB, DeSancho MT, DeAngelis LM.

JAMA Neurol. 2018 Mar 1;75(3):379-381. doi: 10.1001/jamaneurol.2017.4211. No abstract available.

PMID:
29309496
10.

Overview of metastatic disease of the central nervous system.

Nolan C, Deangelis LM.

Handb Clin Neurol. 2018;149:3-23. doi: 10.1016/B978-0-12-811161-1.00001-3.

PMID:
29307359
11.

Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review.

Neil EC, DeAngelis LM.

Blood Adv. 2017 Oct 18;1(23):2041-2045. doi: 10.1182/bloodadvances.2017008201. eCollection 2017 Oct 24.

12.

A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas.

Correa DD, Kryza-Lacombe M, Zhou X, Baser RE, Beattie BJ, Beiene Z, Humm J, DeAngelis LM, Orlow I, Weber W, Osborne J.

J Neurooncol. 2018 Feb;136(3):613-622. doi: 10.1007/s11060-017-2692-5. Epub 2017 Nov 22.

PMID:
29168082
13.

The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.

Mendez JS, Ostrom QT, Gittleman H, Kruchko C, DeAngelis LM, Barnholtz-Sloan JS, Grommes C.

Neuro Oncol. 2018 Apr 9;20(5):687-694. doi: 10.1093/neuonc/nox187.

PMID:
29036697
14.

Novel Considerations in the Approach to Glioblastoma.

Schaff LR, DeAngelis LM.

J Oncol Pract. 2017 Oct;13(10):639-640. doi: 10.1200/JOP.2017.027607. No abstract available.

15.

Long-term outcomes of adult medulloblastoma patients treated with radiotherapy.

De B, Beal K, De Braganca KC, Souweidane MM, Dunkel IJ, Khakoo Y, Gilheeney SW, DeAngelis LM, Menzel P, Patel SH, Wolden SL.

J Neurooncol. 2018 Jan;136(1):95-104. doi: 10.1007/s11060-017-2627-1. Epub 2017 Oct 10.

PMID:
29019042
16.

Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.

Nghiemphu PL, Ebiana VA, Wen P, Gilbert M, Abrey LE, Lieberman F, DeAngelis LM, Robins HI, Yung WKA, Chang S, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados M, Kuhn J, Cloughesy TF.

J Neurooncol. 2018 Jan;136(1):79-86. doi: 10.1007/s11060-017-2624-4. Epub 2017 Oct 7.

PMID:
28988377
17.

Increased risk of arterial thromboembolism in older men with breast cancer.

Reiner AS, Navi BB, DeAngelis LM, Panageas KS.

Breast Cancer Res Treat. 2017 Dec;166(3):903-910. doi: 10.1007/s10549-017-4433-z. Epub 2017 Aug 23.

PMID:
28836029
18.

Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.

Lin X, Fleisher M, Rosenblum M, Lin O, Boire A, Briggs S, Bensman Y, Hurtado B, Shagabayeva L, DeAngelis LM, Panageas KS, Omuro A, Pentsova EI.

Neuro Oncol. 2017 Sep 1;19(9):1248-1254. doi: 10.1093/neuonc/nox066.

PMID:
28821205
19.

Risk of Arterial Thromboembolism in Patients With Cancer.

Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM.

J Am Coll Cardiol. 2017 Aug 22;70(8):926-938. doi: 10.1016/j.jacc.2017.06.047.

PMID:
28818202
20.

Recurrent Thromboembolic Events after Ischemic Stroke in Patients with Primary Brain Tumors.

Parikh NS, Burch JE, Kamel H, DeAngelis LM, Navi BB.

J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2396-2403. doi: 10.1016/j.jstrokecerebrovasdis.2017.05.031. Epub 2017 Jun 21.

PMID:
28647417
21.

Prognostic awareness, prognostic communication, and cognitive function in patients with malignant glioma.

Diamond EL, Prigerson HG, Correa DC, Reiner A, Panageas K, Kryza-Lacombe M, Buthorn J, Neil EC, Miller AM, DeAngelis LM, Applebaum AJ.

Neuro Oncol. 2017 Oct 19;19(11):1532-1541. doi: 10.1093/neuonc/nox117.

PMID:
28645200
22.

Primary CNS Lymphoma.

Grommes C, DeAngelis LM.

J Clin Oncol. 2017 Jul 20;35(21):2410-2418. doi: 10.1200/JCO.2017.72.7602. Epub 2017 Jun 22. Review.

PMID:
28640701
23.

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.

Grommes C, Pastore A, Palaskas N, Tang SS, Campos C, Schartz D, Codega P, Nichol D, Clark O, Hsieh WY, Rohle D, Rosenblum M, Viale A, Tabar VS, Brennan CW, Gavrilovic IT, Kaley TJ, Nolan CP, Omuro A, Pentsova E, Thomas AA, Tsyvkin E, Noy A, Palomba ML, Hamlin P, Sauter CS, Moskowitz CH, Wolfe J, Dogan A, Won M, Glass J, Peak S, Lallana EC, Hatzoglou V, Reiner AS, Gutin PH, Huse JT, Panageas KS, Graeber TG, Schultz N, DeAngelis LM, Mellinghoff IK.

Cancer Discov. 2017 Sep;7(9):1018-1029. doi: 10.1158/2159-8290.CD-17-0613. Epub 2017 Jun 15.

PMID:
28619981
24.

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

Thomas AA, Abrey LE, Terziev R, Raizer J, Martinez NL, Forsyth P, Paleologos N, Matasar M, Sauter CS, Moskowitz C, Nimer SD, DeAngelis LM, Kaley T, Grimm S, Louis DN, Cairncross JG, Panageas KS, Briggs S, Faivre G, Mohile NA, Mehta J, Jonsson P, Chakravarty D, Gao J, Schultz N, Brennan CW, Huse JT, Omuro A.

Neuro Oncol. 2017 Oct 1;19(10):1380-1390. doi: 10.1093/neuonc/nox086.

PMID:
28472509
25.

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.

Nayak L, DeAngelis LM, Brandes AA, Peereboom DM, Galanis E, Lin NU, Soffietti R, Macdonald DR, Chamberlain M, Perry J, Jaeckle K, Mehta M, Stupp R, Muzikansky A, Pentsova E, Cloughesy T, Iwamoto FM, Tonn JC, Vogelbaum MA, Wen PY, van den Bent MJ, Reardon DA.

Neuro Oncol. 2017 May 1;19(5):625-635. doi: 10.1093/neuonc/nox029. Review.

26.

Reappraising the 2016 WHO classification for diffuse glioma.

Lin AL, DeAngelis LM.

Neuro Oncol. 2017 May 1;19(5):609-610. doi: 10.1093/neuonc/nox003. No abstract available.

27.

Longitudinal analysis of treatment-induced genomic alterations in gliomas.

Erson-Omay EZ, Henegariu O, Omay SB, Harmancı AS, Youngblood MW, Mishra-Gorur K, Li J, Özduman K, Carrión-Grant G, Clark VE, Çağlar C, Bakırcıoğlu M, Pamir MN, Tabar V, Vortmeyer AO, Bilguvar K, Yasuno K, DeAngelis LM, Baehring JM, Moliterno J, Günel M.

Genome Med. 2017 Feb 2;9(1):12. doi: 10.1186/s13073-017-0401-9.

28.

Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.

Nayak L, de Groot J, Wefel JS, Cloughesy TF, Lieberman F, Chang SM, Omuro A, Drappatz J, Batchelor TT, DeAngelis LM, Gilbert MR, Aldape KD, Yung AW, Fisher J, Ye X, Chen A, Grossman S, Prados M, Wen PY.

J Neurooncol. 2017 Mar;132(1):181-188. doi: 10.1007/s11060-016-2357-9. Epub 2017 Jan 23.

29.

Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma.

Diamond EL, Panageas KS, Dallara A, Pollock A, Applebaum AJ, Carver AC, Pentsova E, DeAngelis LM, Prigerson HG.

J Pain Symptom Manage. 2017 Feb;53(2):257-264. doi: 10.1016/j.jpainsymman.2016.09.008. Epub 2016 Nov 1.

30.

The confused oncologic patient: a rational clinical approach.

Nolan C, DeAngelis LM.

Curr Opin Neurol. 2016 Dec;29(6):789-796. Review.

31.

A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.

Scordo M, Bhatt V, Hsu M, Omuro AM, Matasar MJ, DeAngelis LM, Dahi PB, Moskowitz CH, Giralt SA, Sauter CS.

Biol Blood Marrow Transplant. 2017 Jan;23(1):38-43. doi: 10.1016/j.bbmt.2016.09.024. Epub 2016 Oct 3.

32.

Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.

Avila EK, Chamberlain M, Schiff D, Reijneveld JC, Armstrong TS, Ruda R, Wen PY, Weller M, Koekkoek JA, Mittal S, Arakawa Y, Choucair A, Gonzalez-Martinez J, MacDonald DR, Nishikawa R, Shah A, Vecht CJ, Warren P, van den Bent MJ, DeAngelis LM.

Neuro Oncol. 2017 Jan;19(1):12-21. doi: 10.1093/neuonc/now190. Epub 2016 Sep 20. Review.

33.

Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences.

de la Fuente MI, Haggiagi A, Moul A, Young RJ, Sidani C, Markoe A, Vega F, DeAngelis LM, Lossos IS.

Leuk Lymphoma. 2017 Apr;58(4):882-888. doi: 10.1080/10428194.2016.1218006. Epub 2016 Sep 21.

34.

Correction regarding data on blinatumomab-associated seizures.

Stone JB, DeAngelis LM.

Nat Rev Clin Oncol. 2016 Oct;13(10):650. doi: 10.1038/nrclinonc.2016.134. Epub 2016 Aug 23. No abstract available.

PMID:
27550852
35.

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid.

Pentsova EI, Shah RH, Tang J, Boire A, You D, Briggs S, Omuro A, Lin X, Fleisher M, Grommes C, Panageas KS, Meng F, Selcuklu SD, Ogilvie S, Distefano N, Shagabayeva L, Rosenblum M, DeAngelis LM, Viale A, Mellinghoff IK, Berger MF.

J Clin Oncol. 2016 Jul 10;34(20):2404-15. doi: 10.1200/JCO.2016.66.6487. Epub 2016 May 9.

36.

OC-02 - Risk of arterial thromboembolism in patients with breast cancer.

Navi BB, Reiner AS, Kamel H, Iadecola C, Elkind MS, Panageas KS, DeAngelis LM.

Thromb Res. 2016 Apr;140 Suppl 1:S169. doi: 10.1016/S0049-3848(16)30119-0. Epub 2016 Apr 8.

PMID:
27161674
37.

Is there a role for early chemotherapy in the management of pituitary adenomas?

Lin AL, Sum MW, DeAngelis LM.

Neuro Oncol. 2016 Oct;18(10):1350-6. doi: 10.1093/neuonc/now059. Epub 2016 Apr 21. Review.

38.

COMT, BDNF, and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors.

Correa DD, Satagopan J, Cheung K, Arora AK, Kryza-Lacombe M, Xu Y, Karimi S, Lyo J, DeAngelis LM, Orlow I.

Neuro Oncol. 2016 Oct;18(10):1425-33. doi: 10.1093/neuonc/now057. Epub 2016 Apr 18.

39.

Chemotherapy-Induced Peripheral Neuropathy.

Tzatha E, DeAngelis LM.

Oncology (Williston Park). 2016 Mar;30(3):240-4. No abstract available.

40.

Cognitive effects of donepezil therapy in patients with brain tumors: a pilot study.

Correa DD, Kryza-Lacombe M, Baser RE, Beal K, DeAngelis LM.

J Neurooncol. 2016 Apr;127(2):313-9. doi: 10.1007/s11060-015-2035-3. Epub 2016 Jan 6.

41.

Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.

Li BT, Lou E, Hsu M, Yu HA, Naidoo J, Zauderer MG, Sima C, Johnson ML, Daras M, DeAngelis LM, Fleisher M, Kris MG, Azzoli CG.

PLoS One. 2016 Jan 5;11(1):e0146063. doi: 10.1371/journal.pone.0146063. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0152450.

42.

Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic Criteria.

Coombs CC, DeAngelis LM, Feusner JH, Rowe JM, Tallman MS.

Clin Lymphoma Myeloma Leuk. 2016 Mar;16(3):146-51. doi: 10.1016/j.clml.2015.11.018. Epub 2015 Nov 22.

43.

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.

de la Fuente MI, Young RJ, Rubel J, Rosenblum M, Tisnado J, Briggs S, Arevalo-Perez J, Cross JR, Campos C, Straley K, Zhu D, Dong C, Thomas A, Omuro AA, Nolan CP, Pentsova E, Kaley TJ, Oh JH, Noeske R, Maher E, Choi C, Gutin PH, Holodny AI, Yen K, DeAngelis LM, Mellinghoff IK, Thakur SB.

Neuro Oncol. 2016 Feb;18(2):283-90. doi: 10.1093/neuonc/nov307. Epub 2015 Dec 20.

44.

Cancer-treatment-induced neurotoxicity--focus on newer treatments.

Stone JB, DeAngelis LM.

Nat Rev Clin Oncol. 2016 Feb;13(2):92-105. doi: 10.1038/nrclinonc.2015.152. Epub 2015 Sep 22. Review.

45.

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.

Nayak L, DeAngelis LM, Robins HI, Govindan R, Gadgeel S, Kelly K, Rigas JR, Peereboom DM, Rosenfeld SS, Muzikansky A, Zheng M, Urban P, Abrey LE, Omuro A, Wen PY.

Cancer. 2015 Dec 1;121(23):4165-72. doi: 10.1002/cncr.29636. Epub 2015 Aug 26.

46.

Treatment of Brain Metastases.

Lin X, DeAngelis LM.

J Clin Oncol. 2015 Oct 20;33(30):3475-84. doi: 10.1200/JCO.2015.60.9503. Epub 2015 Aug 17. Review.

47.

Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors.

Gounder MM, Nayak L, Sahebjam S, Muzikansky A, Sanchez AJ, Desideri S, Ye X, Ivy SP, Nabors LB, Prados M, Grossman S, DeAngelis LM, Wen PY.

J Clin Oncol. 2015 Oct 1;33(28):3186-92. doi: 10.1200/JCO.2015.61.1525. Epub 2015 Aug 17.

48.

Rates and risks for late referral to hospice in patients with primary malignant brain tumors.

Diamond EL, Russell D, Kryza-Lacombe M, Bowles KH, Applebaum AJ, Dennis J, DeAngelis LM, Prigerson HG.

Neuro Oncol. 2016 Jan;18(1):78-86. doi: 10.1093/neuonc/nov156. Epub 2015 Aug 9.

49.

Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.

Singer S, Grommes C, Reiner AS, Rosenblum MK, DeAngelis LM.

Oncologist. 2015 Jul;20(7):806-11. doi: 10.1634/theoncologist.2014-0149. Epub 2015 Jun 1.

50.

Neuro-oncology: Primary CNS lymphoma treatment--the devil is in the details.

DeAngelis LM.

Nat Rev Neurol. 2015 Jun;11(6):314-5. doi: 10.1038/nrneurol.2015.64. Epub 2015 May 5. No abstract available.

PMID:
25939273

Supplemental Content

Loading ...
Support Center